These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26094838)

  • 1. Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.
    Trotti LM; Saini P; Bliwise DL; Freeman AA; Jenkins A; Rye DB
    Ann Neurol; 2015 Sep; 78(3):454-65. PubMed ID: 26094838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience.
    Trotti LM; Saini P; Freeman AA; Bliwise DL; García PS; Jenkins A; Rye DB
    J Psychopharmacol; 2014 Jul; 28(7):697-702. PubMed ID: 24306133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
    Puymirat J; Bouchard JP; Mathieu J
    Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of armodafinil on objective sleepiness and performance in a shift work disorder sample unselected for objective sleepiness.
    Howard R; Roth T; Drake CL
    J Clin Psychopharmacol; 2014 Jun; 34(3):369-73. PubMed ID: 24717254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients.
    Trotti LM; Saini P; Koola C; LaBarbera V; Bliwise DL; Rye DB
    J Clin Sleep Med; 2016 Oct; 12(10):1389-1394. PubMed ID: 27568889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Psychomotor Vigilance Test as a measure of alertness and sleep inertia in people with central disorders of hypersomnolence.
    Trotti LM; Saini P; Bremer E; Mariano C; Moron D; Rye DB; Bliwise DL
    J Clin Sleep Med; 2022 May; 18(5):1395-1403. PubMed ID: 35040431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized placebo-controlled trial of pantoprazole for daytime sleepiness in GERD and obstructive sleep disordered breathing.
    Suurna MV; Welge J; Surdulescu V; Kushner J; Steward DL
    Otolaryngol Head Neck Surg; 2008 Aug; 139(2):286-90. PubMed ID: 18656731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
    Eggert K; Öhlwein C; Kassubek J; Wolz M; Kupsch A; Ceballos-Baumann A; Ehret R; Polzer U; Klostermann F; Schwarz J; Fuchs G; Jost W; Albert A; Haag A; Hermsen A; Lohmüller K; Kuhn K; Wangemann M; Oertel WH;
    Clin Neuropharmacol; 2014; 37(4):116-22. PubMed ID: 24992083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.
    Kingshott RN; Vennelle M; Coleman EL; Engleman HM; Mackay TW; Douglas NJ
    Am J Respir Crit Care Med; 2001 Mar; 163(4):918-23. PubMed ID: 11282766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial.
    Williams SC; Marshall NS; Kennerson M; Rogers NL; Liu PY; Grunstein RR
    Am J Respir Crit Care Med; 2010 Apr; 181(8):825-31. PubMed ID: 20056901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of loratadine/montelukast on vigilance and alertness task performance in a simulated cabin environment.
    Valk PJ; Simons M
    Adv Ther; 2009 Jan; 26(1):89-98. PubMed ID: 19089321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
    Czeisler CA; Walsh JK; Roth T; Hughes RJ; Wright KP; Kingsbury L; Arora S; Schwartz JR; Niebler GE; Dinges DF;
    N Engl J Med; 2005 Aug; 353(5):476-86. PubMed ID: 16079371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.